These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23434948)

  • 1. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic.
    Hell M; Bernhofer C; Stalzer P; Kern JM; Claassen E
    Benef Microbes; 2013 Mar; 4(1):39-51. PubMed ID: 23434948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is primary prevention of Clostridium difficile infection possible with specific probiotics?
    Johnson S; Maziade PJ; McFarland LV; Trick W; Donskey C; Currie B; Low DE; Goldstein EJ
    Int J Infect Dis; 2012 Nov; 16(11):e786-92. PubMed ID: 22863358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Bacillus subtilis PXN21 spores for suppression of Clostridium difficile infection symptoms in a murine model.
    Colenutt C; Cutting SM
    FEMS Microbiol Lett; 2014 Sep; 358(2):154-61. PubMed ID: 24828432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.
    McFarland LV
    Anaerobe; 2009 Dec; 15(6):274-80. PubMed ID: 19825425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile: controversies and approaches to management.
    Bauer MP; van Dissel JT; Kuijper EJ
    Curr Opin Infect Dis; 2009 Dec; 22(6):517-24. PubMed ID: 19738464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections.
    McFarland LV
    Benef Microbes; 2015; 6(2):189-94. PubMed ID: 24889895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics for prevention of Clostridium difficile infection.
    Mills JP; Rao K; Young VB
    Curr Opin Gastroenterol; 2018 Jan; 34(1):3-10. PubMed ID: 29189354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection: A brief update on emerging therapies.
    Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
    Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal transplantation for the treatment of Clostridium difficile infection: a review.
    McCune VL; Struthers JK; Hawkey PM
    Int J Antimicrob Agents; 2014 Mar; 43(3):201-6. PubMed ID: 24636428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Clostridium difficile Infection With Probiotics.
    Evans CT; Johnson S
    Clin Infect Dis; 2015 May; 60 Suppl 2():S122-8. PubMed ID: 25922397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infections: emerging epidemiology and new treatments.
    Cohen MB
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S63-5. PubMed ID: 19300129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options.
    Lo Vecchio A; Zacur GM
    Curr Opin Gastroenterol; 2012 Jan; 28(1):1-9. PubMed ID: 22134217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection.
    Rea MC; Alemayehu D; Ross RP; Hill C
    J Med Microbiol; 2013 Sep; 62(Pt 9):1369-1378. PubMed ID: 23699066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.
    Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM
    Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new strategy for the prevention of Clostridium difficile infection.
    Howerton A; Patra M; Abel-Santos E
    J Infect Dis; 2013 May; 207(10):1498-504. PubMed ID: 23420906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea.
    Surawicz CM
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S64-70. PubMed ID: 18545161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
    Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
    Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics for infectious diseases: more drugs, less dietary supplementation.
    Kotzampassi K; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2012 Oct; 40(4):288-96. PubMed ID: 22858373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.